Abstract 9 Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Leads to Robust Recovery and Diversity of T Cells

INTRODUCTION: Omidubicel is a cell therapy used for allogeneic hematopoietic stem cell transplant. A phase III randomized study (NCT02730299) comparing omidubicel to umbilical cord blood (UCB) demonstrated faster hematopoietic recovery, lower rates of infection, shorter hospitalization time (Horwitz...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabolcs, Paul, Yackoubov, Dima, Levy, Stuart, Chen, Xiaohua, Horwitz, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trials – Hematopoietic Stem Cell Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446948/
http://dx.doi.org/10.1093/stcltm/szac057.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446948/
http://dx.doi.org/10.1093/stcltm/szac057.009

Ejemplares similares